Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MDA-MB-436
TNBC
Basal B
GSK923295
CENPE
Kinesin
7899.001
uM
0.13542
0.02455
0.1682 0.4192 1.0672 0.3091
0.7940
2.0444
MDA-MB-436
TNBC
Basal B
GSK923295
CENPE
Kinesin
10266.001
uM
0.01345
0.01380
-0.1922 -0.0242 1.8703 0.6598
0.8030
0.8138
MDA-MB-436
TNBC
Basal B
GSK923295
CENPE
Kinesin
7900.001
uM
0.01148
0.05060
-0.2775 -0.3310 0.3425 0.6711
0.8630
0.7944
MDA-MB-436
TNBC
Basal B
GSK923295
CENPE
Kinesin
7898.001
uM
0.01705
0.01656
-0.0566 0.0346 2.4382 0.5937
0.9091
1.2337
MDA-MB-436
TNBC
Basal B
LY294002
PI3K
PI3K
7898.029
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.7130
MDA-MB-436
TNBC
Basal B
Oxaliplatin
DNA cross-linker
DNA cross-linker
7902.075
uM
90.53730
533.29250
-0.0929 -1.0000 0.6195 0.2153
0.9315
1.9585
MDA-MB-436
TNBC
Basal B
Oxaliplatin
DNA cross-linker
DNA cross-linker
7898.011
uM
65.23630
222.79440
-0.4440 -1.0000 0.8945 0.2544
0.9590
1.0373
MDA-MB-436
TNBC
Basal B
Oxaliplatin
DNA cross-linker
DNA cross-linker
10266.011
uM
30.96790
102.12640
-0.7782 -1.0000 0.9207 0.3143
0.9797
0.6895
MDA-MB-436
TNBC
Basal B
Oxaliplatin
DNA cross-linker
DNA cross-linker
7900.011
uM
86.94260
106.4080
-0.8727 -0.8730 5.0000 0.2400
0.9959
0.5977
MDA-MB-436
TNBC
Basal B
PD184352
MEK
MAPK
7898.029
uM
inf
inf
1.0500 1.0500 0.0000 0.0820
0.0614
0.7130
MDA-MB-436
TNBC
Basal B
PD184352
MEK
MAPK
7898.029
uM
inf
inf
1.0500 1.0500 0.0000 0.0820
0.0614
0.7130
MDA-MB-436
TNBC
Basal B
Sirolimus
MTOR
MTOR
7899.068
uM
inf
inf
0.3480 0.3480 0.0000 0.2228
0.3774
1.9316
MDA-MB-436
TNBC
Basal B
Taxol
TUBB
TUBB
10266.002
uM
0.01263
0.02198
-0.6138 -0.3854 1.0308 0.7789
0.9445
0.6757
MDA-MB-436
TNBC
Basal B
Taxol
TUBB
TUBB
7900.002
uM
0.05337
0.05943
-0.4792 -0.3560 4.9999 0.6534
0.9479
0.4748
MDA-MB-436
TNBC
Basal B
Taxol
TUBB
TUBB
7898.002
uM
0.03169
0.03472
-0.2253 -0.1630 3.0900 0.6203
0.9950
1.1328
MDA-MB-436
TNBC
Basal B
Topotecan
TOP1
TOP
7899.077
uM
0.03068
0.02655
-0.2010 0.0442 0.6406 0.5943
0.8838
2.1925
MDA-MB-436
TNBC
Basal B
Topotecan
TOP1
TOP
10266.121
uM
0.02557
0.02937
-0.7058 -0.4997 4.9983 1.0020
0.9380
0.7110
MDA-MB-436
TNBC
Basal B
Trametinib
MEK
MAPK
7900.012
uM
inf
inf
0.4439 0.4439 0.0000 0.5210
-0.1349
0.8090
MDA-MB-436
TNBC
Basal B
Trametinib
MEK
MAPK
7900.036
uM
inf
inf
0.1830 0.1830 0.0000 0.2760
0.0114
0.7997
MDA-MB-436
TNBC
Basal B
Trametinib
MEK
MAPK
7902.05
uM
inf
inf
0.6492 0.6492 0.0000 0.1023
0.0604
1.8149
MDA-MB-436
TNBC
Basal B
Trametinib
MEK
MAPK
10266.024
uM
inf
inf
0.1069 0.1069 0.0000 0.1775
0.4772
0.6533
MDA-MB-436
TNBC
Basal B
Trametinib
MEK
MAPK
7898.036
uM
inf
inf
0.4847 0.4847 0.0000 0.1320
0.5322
1.1276
MDA-MB-436
TNBC
Basal B
Trastuzumab
HER2
ErbB
10266.026
uM
inf
inf
0.0817 0.0817 0.0000 0.1773
0.3932
0.6682
MDA-MB-436
TNBC
Basal B
U-0126
MEK
MAPK
7898.029
uM
inf
inf
0.8073 0.8073 0.0000 0.0952
-0.0166
0.7130
MDA-MB-436
TNBC
Basal B
Vinorelbine
TUBB
TUBB
7900.018
uM
0.00034
0.00766
-0.9981 -0.8167 0.3116 1.1293
0.8603
0.8304